A Study of Demcizumab Plus Paclitaxel in Subjects With Platinum Resistant Ovarian

Clinical trial NCT01952249 · TERMINATED

Trial details

NCT number: NCT01952249
Sponsor: OncoMed Pharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Primary Peritoneal Carcinoma

Start date: 2013-08-05
Primary completion: 2016-05-10
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.